Citrus Sinensis ID: 011480

Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480----
MPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
ccccccccHHHHHHHHHHHccccccEEcccccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHcccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEEEcccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHccccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHcccccccEEEEEcccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHccccccccEEEEccccccHHHHHHHHHHHHHcccccccEEEcccccccHHHHHHHHHHHHHccccccEEEEEcc
cccccccccHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHHcccccEEEccccccHHHHHHHHHHHHcccccEEEEEEccccccHHHHHHHHHHHHHcccccEEEcccccccHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHHcccccEEEccccEcHHHHHHHHHHHHHcccccccEEEccccccEHHHHHHHHHHHHHcccccEEEccccEccHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHccccccEEEcccccccHHHHHHHHHHHHccccccEEEEcccccccHHHHHHHHHHHHHccccEEEEEEcccccccHHHHHHHHHHHcccccHHEEEEEEcc
mpkpsrpskptaegmnwsvgagtnllsgftgKLFRESKQTLNEFAKELRAFSsvdmsgrnfgdeGLFFLAESlgynqtaeevsfAANGITAAGIKAFDGVLQSNIALktlnlsgnpigdegVKCLCDILvdnagverlqlssVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTirslhlngnyggaLGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDignnsisakGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQnrtittidlggnnihskGASAIARVLkdnsvitsldlaynpigaDGAKALSEVLKFHGnintlklgwcqigaSGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
mpkpsrpskptaegmnwsvgaGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTIttidlggnnihSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
MPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHlngnyggalganalakglegnKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
****************WSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYE**********
*****************SVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
************EGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
******PSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MPKPSRPSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

Original result of BLAST against SWISS-PROT Database

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query484 2.2.26 [Sep-21-2011]
Q7RTR21065 Protein NLRC3 OS=Homo sap yes no 0.884 0.401 0.360 1e-52
Q5DU561064 Protein NLRC3 OS=Mus musc yes no 0.869 0.395 0.340 3e-45
P29315456 Ribonuclease inhibitor OS yes no 0.799 0.848 0.264 2e-27
Q91VI7456 Ribonuclease inhibitor OS no no 0.745 0.791 0.274 3e-26
P10775456 Ribonuclease inhibitor OS no no 0.756 0.802 0.264 4e-26
Q647I91098 NACHT, LRR and PYD domain no no 0.710 0.313 0.281 2e-25
P13489461 Ribonuclease inhibitor OS no no 0.838 0.880 0.265 7e-24
Q9LE82535 RAN GTPase-activating pro no no 0.659 0.596 0.270 1e-23
Q8HZP9461 Ribonuclease inhibitor OS no no 0.838 0.880 0.265 2e-23
Q86WI31866 Protein NLRC5 OS=Homo sap no no 0.685 0.177 0.283 2e-23
>sp|Q7RTR2|NLRC3_HUMAN Protein NLRC3 OS=Homo sapiens GN=NLRC3 PE=2 SV=2 Back     alignment and function desciption
 Score =  207 bits (527), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 156/433 (36%), Positives = 232/433 (53%), Gaps = 5/433 (1%)

Query: 37   SKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESL-GYNQTAEEVSFAANGITAAGIK 95
            S+  L     +L     + +    F D  +  L   L G +   +++S A N I+  G K
Sbjct: 625  SQGVLQSLLPQLLYCRKLRLDTNQFQDPVMELLGSVLSGKDCRIQKISLAENQISNKGAK 684

Query: 96   AFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAE 155
            A    L  N +L +L+L GN IG +G K L D L  N  +  L L    +RD+GA+++AE
Sbjct: 685  ALARSLLVNRSLTSLDLRGNSIGPQGAKALADALKINRTLTSLSLQGNTVRDDGARSMAE 744

Query: 156  LLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIRSLHLNGNYGGALGANALAKGLEG 215
             L +N  L +L L  N I   G   +A+AL +N +++ L  + N  G  GA ALA+ L+ 
Sbjct: 745  ALASNRTLSMLHLQKNSIGPMGAQRMADALKQNRSLKELMFSSNSIGDGGAKALAEALKV 804

Query: 216  NKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKS 275
            N+ L  L L  NSI D G+ ALM  L + +  L+ L +  NSIS +GA  +A  +    +
Sbjct: 805  NQGLESLDLQSNSISDAGVAALMGALCTNQTLLS-LSLRENSISPEGAQAIAHALCANST 863

Query: 276  LLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSL 335
            L  ++L  N + D+GA  IA A+++NRT+T++ L  N I +  A A+ + L+ N  +TSL
Sbjct: 864  LKNLDLTANLLHDQGARAIAVAVRENRTLTSLHLQWNFIQAGAAQALGQALQLNRSLTSL 923

Query: 336  DLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRA 395
            DL  N IG DGA A++  LK +  +  L L    IGASGA+ + + L  N T+ ILDLR 
Sbjct: 924  DLQENAIGDDGACAVARALKVNTALTALYLQVASIGASGAQVLGEALAVNRTLEILDLRG 983

Query: 396  NGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANN 455
            N +   GAK LA + K VN +L  ++L  N +  DGA  IA AL  N    +  +NL  N
Sbjct: 984  NAIGVAGAKALANALK-VNSSLRRLNLQENSLGMDGAICIATALSGNHR--LQHINLQGN 1040

Query: 456  FLTKFGQSALTDA 468
             +   G   +++A
Sbjct: 1041 HIGDSGARMISEA 1053
May modulate T-cell activation. Decreases the transcription of genes that are normally up-regulated after T-cell stimulation. Delays degradation of NFKBIA/IKBA.
Homo sapiens (taxid: 9606)
>sp|Q5DU56|NLRC3_MOUSE Protein NLRC3 OS=Mus musculus GN=Nlrc3 PE=2 SV=2 Back     alignment and function description
>sp|P29315|RINI_RAT Ribonuclease inhibitor OS=Rattus norvegicus GN=Rnh1 PE=1 SV=2 Back     alignment and function description
>sp|Q91VI7|RINI_MOUSE Ribonuclease inhibitor OS=Mus musculus GN=Rnh1 PE=1 SV=1 Back     alignment and function description
>sp|P10775|RINI_PIG Ribonuclease inhibitor OS=Sus scrofa GN=RNH1 PE=1 SV=1 Back     alignment and function description
>sp|Q647I9|NALP5_BOVIN NACHT, LRR and PYD domains-containing protein 5 OS=Bos taurus GN=NLRP5 PE=2 SV=1 Back     alignment and function description
>sp|P13489|RINI_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 Back     alignment and function description
>sp|Q9LE82|RAGP1_ARATH RAN GTPase-activating protein 1 OS=Arabidopsis thaliana GN=RANGAP1 PE=1 SV=1 Back     alignment and function description
>sp|Q8HZP9|RINI_PANTR Ribonuclease inhibitor OS=Pan troglodytes GN=RNH1 PE=2 SV=3 Back     alignment and function description
>sp|Q86WI3|NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

Original result of BLAST against Nonredundant Database

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query484
359473416 684 PREDICTED: protein NLRC3-like [Vitis vin 0.975 0.690 0.824 0.0
296086512 630 unnamed protein product [Vitis vinifera] 0.973 0.747 0.825 0.0
297843864 605 EMB2004 [Arabidopsis lyrata subsp. lyrat 0.997 0.798 0.796 0.0
18391166 605 leucine-rich repeats-ribonuclease inhibi 0.997 0.798 0.792 0.0
224100227490 predicted protein [Populus trichocarpa] 1.0 0.987 0.787 0.0
357486129 606 Nucleotide-binding oligomerization domai 0.997 0.797 0.766 0.0
255558382 607 leucine rich repeat-containing protein, 1.0 0.797 0.782 0.0
356501981 606 PREDICTED: protein NLRC3-like [Glycine m 1.0 0.798 0.773 0.0
356498020 606 PREDICTED: protein NLRC3-like [Glycine m 1.0 0.798 0.753 0.0
258678027 614 chloroplast envelope protein 1 [Nicotian 0.997 0.786 0.742 0.0
>gi|359473416|ref|XP_002266381.2| PREDICTED: protein NLRC3-like [Vitis vinifera] Back     alignment and taxonomy information
 Score =  795 bits (2053), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/472 (82%), Positives = 425/472 (90%)

Query: 13  EGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAES 72
            G+ WS   GTNLL+G T K  RESKQ LNEFAKE+R+F SVDMSGRNFGDEGLFFLAES
Sbjct: 213 PGVKWSFAPGTNLLAGLTAKFDRESKQKLNEFAKEIRSFGSVDMSGRNFGDEGLFFLAES 272

Query: 73  LGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDN 132
           L YNQ AEEVSFAANGITAAG+KAFDGVLQSNI LKTL+LSGNPIGDEG KCLCDIL+DN
Sbjct: 273 LAYNQNAEEVSFAANGITAAGLKAFDGVLQSNIVLKTLDLSGNPIGDEGAKCLCDILIDN 332

Query: 133 AGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTIR 192
           AG+++LQL+S DL DEGAKAIAE+LK NS LR++ELNNNMIDYSGFTSL  ALLEN+TIR
Sbjct: 333 AGIQKLQLNSADLGDEGAKAIAEMLKKNSSLRIVELNNNMIDYSGFTSLGGALLENNTIR 392

Query: 193 SLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLD 252
           ++HLNGNYGGALG  ALAKGLE NKSLRELHLHGNSIGDEG+R LMSGLSS KGKL +LD
Sbjct: 393 NIHLNGNYGGALGVAALAKGLEANKSLRELHLHGNSIGDEGVRVLMSGLSSHKGKLTLLD 452

Query: 253 IGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGN 312
           IGNN IS++GAFHVAEYIK  KSLLW+NLYMNDIGDEGAEKIADALK+NR+I TIDLGGN
Sbjct: 453 IGNNEISSRGAFHVAEYIKKAKSLLWLNLYMNDIGDEGAEKIADALKENRSIATIDLGGN 512

Query: 313 NIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNINTLKLGWCQIGA 372
           NIH+KG S IA VLKDN+VIT+L+L YNPIG +GAKALSEVLKFHG I TLKLGWCQIGA
Sbjct: 513 NIHAKGVSKIAGVLKDNTVITTLELGYNPIGPEGAKALSEVLKFHGKIKTLKLGWCQIGA 572

Query: 373 SGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGA 432
            GAEF+AD L+YN TIS LDLRANGLRDEGA CLA+S KVVNEAL S+DL FNEIRD+GA
Sbjct: 573 KGAEFIADTLKYNTTISTLDLRANGLRDEGAVCLARSMKVVNEALASLDLGFNEIRDEGA 632

Query: 433 FAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEVNIFF 484
           FAIAQALKANEDVAVTSLNLA+NFLTKFGQSALTDA+D VYEMSEKEVNIFF
Sbjct: 633 FAIAQALKANEDVAVTSLNLASNFLTKFGQSALTDARDHVYEMSEKEVNIFF 684

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota
>gi|296086512|emb|CBI32101.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
>gi|297843864|ref|XP_002889813.1| EMB2004 [Arabidopsis lyrata subsp. lyrata] gi|297335655|gb|EFH66072.1| EMB2004 [Arabidopsis lyrata subsp. lyrata] Back     alignment and taxonomy information
>gi|18391166|ref|NP_563871.1| leucine-rich repeats-ribonuclease inhibitor domain-containing protein [Arabidopsis thaliana] gi|15810395|gb|AAL07085.1| unknown protein [Arabidopsis thaliana] gi|20258921|gb|AAM14154.1| unknown protein [Arabidopsis thaliana] gi|332190466|gb|AEE28587.1| leucine-rich repeats-ribonuclease inhibitor domain-containing protein [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|224100227|ref|XP_002311795.1| predicted protein [Populus trichocarpa] gi|222851615|gb|EEE89162.1| predicted protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|357486129|ref|XP_003613352.1| Nucleotide-binding oligomerization domain-containing protein [Medicago truncatula] gi|355514687|gb|AES96310.1| Nucleotide-binding oligomerization domain-containing protein [Medicago truncatula] Back     alignment and taxonomy information
>gi|255558382|ref|XP_002520218.1| leucine rich repeat-containing protein, putative [Ricinus communis] gi|223540710|gb|EEF42273.1| leucine rich repeat-containing protein, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|356501981|ref|XP_003519801.1| PREDICTED: protein NLRC3-like [Glycine max] Back     alignment and taxonomy information
>gi|356498020|ref|XP_003517853.1| PREDICTED: protein NLRC3-like [Glycine max] Back     alignment and taxonomy information
>gi|258678027|gb|ACV87735.1| chloroplast envelope protein 1 [Nicotiana benthamiana] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

Original result of BLAST against Gene Ontology (AMIGO)

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query484
TAIR|locus:2194604605 emb2004 "embryo defective 2004 0.997 0.798 0.754 3.1e-193
UNIPROTKB|Q7RTR21065 NLRC3 "Protein NLRC3" [Homo sa 0.884 0.401 0.339 4.7e-52
MGI|MGI:24440701064 Nlrc3 "NLR family, CARD domain 0.869 0.395 0.319 1.9e-46
RGD|2321956456 LOC100360501 "ribonuclease inh 0.768 0.815 0.269 2.8e-29
RGD|621398456 Rnh1 "ribonuclease/angiogenin 0.783 0.831 0.264 5.2e-29
MGI|MGI:1195456456 Rnh1 "ribonuclease/angiogenin 0.745 0.791 0.266 2.4e-27
UNIPROTKB|P10775456 RNH1 "Ribonuclease inhibitor" 0.795 0.844 0.263 2.4e-27
UNIPROTKB|P13489461 RNH1 "Ribonuclease inhibitor" 0.820 0.861 0.258 2.1e-26
RGD|1562269953 Nod1 "nucleotide-binding oligo 0.464 0.236 0.330 4.1e-25
ZFIN|ZDB-GENE-110913-19 1252 si:dkey-156k2.3 "si:dkey-156k2 0.801 0.309 0.257 1.1e-24
TAIR|locus:2194604 emb2004 "embryo defective 2004" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 1872 (664.0 bits), Expect = 3.1e-193, P = 3.1e-193
 Identities = 365/484 (75%), Positives = 412/484 (85%)

Query:     2 PKPSR-PSKPTAEGMNWSVGAGTNLLSGFTGKLFRESKQTLNEFAKELRAFSSVDMSGRN 60
             PK S   +  + +G+ WS+GAGTNLL GF  K+ RE+KQ LNEFAKELR+F SVDMSG N
Sbjct:   122 PKTSAGENNSSTQGVKWSIGAGTNLLQGFAAKVDREAKQRLNEFAKELRSFRSVDMSGCN 181

Query:    61 FGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDE 120
             FGDEGLFFLAESLGYNQT EEVSF+ANGITAAG+KAFDGVLQSNI LK LNLSGNPIGDE
Sbjct:   182 FGDEGLFFLAESLGYNQTVEEVSFSANGITAAGVKAFDGVLQSNIMLKILNLSGNPIGDE 241

Query:   121 GVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTS 180
             G K LC  L++N+ +E LQL+S D+ DEGAK IAELLK NS LR++ELNNNMIDYSGFTS
Sbjct:   242 GAKTLCATLMENSSIEILQLNSTDIGDEGAKEIAELLKRNSTLRIIELNNNMIDYSGFTS 301

Query:   181 LAEALLENSTIRSLHXXXXXXXXXXXXXXXXXXXXXKSLRELHLHGNSIGDEGIRALMSG 240
             LA ALLEN+TIR+LH                     KSLRELHLHGNSIGDEG RALM+G
Sbjct:   302 LAGALLENNTIRNLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGTRALMAG 361

Query:   241 LSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQ 300
             LSS KGK+A+LD+GNNSISAKGAF+VAEYIK  KSL+W+NLYMNDIGDEGAEKIAD+LKQ
Sbjct:   362 LSSHKGKVALLDLGNNSISAKGAFYVAEYIKRSKSLVWLNLYMNDIGDEGAEKIADSLKQ 421

Query:   301 NRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFHGNI 360
             NR+I TIDLGGNNIH++G +AIA+ LKDN++IT+L++ YNPIG DGAKALSE+LKFHGN+
Sbjct:   422 NRSIATIDLGGNNIHAEGVNAIAQALKDNAIITTLEVGYNPIGPDGAKALSEILKFHGNV 481

Query:   361 NTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSI 420
              TLKLGWCQI A GAE VADMLRYNNTIS+LDLRANGLRDEGA CLA+S KVVNEALTS+
Sbjct:   482 KTLKLGWCQIAAKGAEHVADMLRYNNTISVLDLRANGLRDEGASCLARSLKVVNEALTSV 541

Query:   421 DLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYEMSEKEV 480
             DL FNEIRDDGAFAIAQALKANEDV VTS+NL NNF+TKFGQSALTDA+D V EM+EKEV
Sbjct:   542 DLGFNEIRDDGAFAIAQALKANEDVTVTSINLGNNFITKFGQSALTDARDHVLEMTEKEV 601

Query:   481 NIFF 484
              IFF
Sbjct:   602 EIFF 605
GO:0005739 "mitochondrion" evidence=ISM;IDA
GO:0009793 "embryo development ending in seed dormancy" evidence=NAS
GO:0009941 "chloroplast envelope" evidence=IDA
GO:0009536 "plastid" evidence=IDA
GO:0009507 "chloroplast" evidence=IDA
UNIPROTKB|Q7RTR2 NLRC3 "Protein NLRC3" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
MGI|MGI:2444070 Nlrc3 "NLR family, CARD domain containing 3" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
RGD|2321956 LOC100360501 "ribonuclease inhibitor-like" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
RGD|621398 Rnh1 "ribonuclease/angiogenin inhibitor 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
MGI|MGI:1195456 Rnh1 "ribonuclease/angiogenin inhibitor 1" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
UNIPROTKB|P10775 RNH1 "Ribonuclease inhibitor" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|P13489 RNH1 "Ribonuclease inhibitor" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
RGD|1562269 Nod1 "nucleotide-binding oligomerization domain containing 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-110913-19 si:dkey-156k2.3 "si:dkey-156k2.3" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Original result from the STRING server

Your Input:
GSVIVG00028885001
SubName- Full=Chromosome chr1 scaffold_46, whole genome shotgun sequence; (536 aa)
(Vitis vinifera)
Predicted Functional Partners:
 
Sorry, there are no predicted associations at the current settings.
 

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against CDD database part I

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query484
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 5e-37
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 6e-35
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 3e-30
cd00116319 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo 3e-27
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 1e-07
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 1e-06
COG5238388 COG5238, RNA1, Ran GTPase-activating protein (RanG 3e-05
smart0036828 smart00368, LRR_RI, Leucine rich repeat, ribonucle 7e-04
COG5238 388 COG5238, RNA1, Ran GTPase-activating protein (RanG 8e-04
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information 
 Score =  138 bits (349), Expect = 5e-37
 Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 32/291 (10%)

Query: 43  EFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAA---------------- 86
           E   +L     + + G   G+E    LA +L    + +E+  +                 
Sbjct: 17  ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQG 76

Query: 87  --------------NGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVDN 132
                         N +   G    + +L+S+ +L+ L L+ N +GD G++ L   L D 
Sbjct: 77  LTKGCGLQELDLSDNALGPDGCGVLESLLRSS-SLQELKLNNNGLGDRGLRLLAKGLKDL 135

Query: 133 A-GVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENSTI 191
              +E+L L    L     +A+A+ L+ N  L+ L L NN I  +G  +LAE L  N  +
Sbjct: 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL 195

Query: 192 RSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVL 251
             L LN N     GA+ALA+ L   KSL  L+L  N++ D G  AL S L S    L  L
Sbjct: 196 EVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255

Query: 252 DIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNR 302
            +  N I+  GA  +AE +   +SLL ++L  N  G+EGA+ +A++L +  
Sbjct: 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPG 306

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>gnl|CDD|197686 smart00368, LRR_RI, Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

Original result of HHsearch against CDD database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 484
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.97
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.97
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.96
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 99.95
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.94
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.94
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.93
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.9
KOG4308478 consensus LRR-containing protein [Function unknown 99.85
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.84
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.79
KOG4308478 consensus LRR-containing protein [Function unknown 99.79
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.75
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 99.72
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.67
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.66
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.63
KOG4341483 consensus F-box protein containing LRR [General fu 99.6
KOG4341483 consensus F-box protein containing LRR [General fu 99.56
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.54
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 99.52
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.51
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.48
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.48
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.42
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 99.42
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.39
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.36
KOG4237498 consensus Extracellular matrix protein slit, conta 99.28
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 99.26
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 99.25
KOG4237498 consensus Extracellular matrix protein slit, conta 99.1
KOG0617264 consensus Ras suppressor protein (contains leucine 98.96
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.84
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.83
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.83
KOG0617264 consensus Ras suppressor protein (contains leucine 98.81
KOG1947482 consensus Leucine rich repeat proteins, some prote 98.68
KOG1947482 consensus Leucine rich repeat proteins, some prote 98.6
KOG2982 418 consensus Uncharacterized conserved protein [Funct 98.52
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.51
KOG2982418 consensus Uncharacterized conserved protein [Funct 98.5
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 98.47
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 98.44
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.31
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 98.28
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 98.25
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.18
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 97.97
PLN03150623 hypothetical protein; Provisional 97.92
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 97.89
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 97.85
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.82
KOG4242553 consensus Predicted myosin-I-binding protein [Cell 97.74
PLN03150623 hypothetical protein; Provisional 97.73
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 97.69
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.68
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 97.62
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.37
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 97.32
KOG4242553 consensus Predicted myosin-I-binding protein [Cell 97.29
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.23
KOG3735353 consensus Tropomodulin and leiomodulin [Cytoskelet 97.19
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.14
KOG3864221 consensus Uncharacterized conserved protein [Funct 97.1
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.06
KOG2123 388 consensus Uncharacterized conserved protein [Funct 96.98
KOG3735353 consensus Tropomodulin and leiomodulin [Cytoskelet 96.87
KOG3864221 consensus Uncharacterized conserved protein [Funct 96.79
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 96.61
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 96.56
smart0036828 LRR_RI Leucine rich repeat, ribonuclease inhibitor 96.53
KOG2123388 consensus Uncharacterized conserved protein [Funct 96.52
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 96.33
PF1351624 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RI 95.96
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 95.91
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 95.87
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 95.35
PRK15386 426 type III secretion protein GogB; Provisional 94.51
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 93.3
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 92.8
PRK15386426 type III secretion protein GogB; Provisional 92.76
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 89.52
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 86.67
KOG3763 585 consensus mRNA export factor TAP/MEX67 [RNA proces 82.87
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information 
Probab=99.97  E-value=2.8e-28  Score=231.17  Aligned_cols=313  Identities=31%  Similarity=0.410  Sum_probs=186.8

Q ss_pred             EecCCCCCChhHHHHHHHHHHhCCCcCEEEeeccCCChHHHHHHHHHHhcCCCccEEEccCCCCC--chHHHHHHHHHhc
Q 011480          110 LNLSGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMID--YSGFTSLAEALLE  187 (484)
Q Consensus       110 L~L~~~~i~~~~~~~l~~~l~~~~~L~~L~l~~~~~~~~~~~~l~~~l~~~~~L~~L~l~~~~l~--~~~~~~l~~~l~~  187 (484)
                      |+|..+.++...+..+...+   ..|++|+++++.+++.+...++..+...+.+++++++++.+.  ..++..++.++..
T Consensus         3 l~L~~~~l~~~~~~~~~~~l---~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~   79 (319)
T cd00116           3 LSLKGELLKTERATELLPKL---LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTK   79 (319)
T ss_pred             cccccCcccccchHHHHHHH---hhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHh
Confidence            45555555544433333322   446777777777666666666666666666777777666665  4455555556666


Q ss_pred             CCCccEEEcCCCCCChHHHHHHHHHhhcCCCcCEEEccCCCCChhHHHHHHHhhccCCCcceEEEccCCCCChhhHHHHH
Q 011480          188 NSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVA  267 (484)
Q Consensus       188 ~~~L~~L~l~~~~~~~~~~~~l~~~l~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~~~~~L~~L~l~~~~i~~~~~~~l~  267 (484)
                      +++|+.|++++|.+.......+...... ++|++|++++|.+++.+...+...+....++|++|++++|.++..+...+.
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~  158 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA  158 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhcc-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence            6666666666666654333333333333 557777777766665555555544443323666677776666655555555


Q ss_pred             HHHhcCCCCcEEEcCCCCCCcHHHHHHHHHHHhCCCccEEEccCCCCChhHHHHHHHHhhcCCCcCEEECCCCCCChhHH
Q 011480          268 EYIKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGA  347 (484)
Q Consensus       268 ~~l~~~~~L~~L~l~~~~l~~~~~~~l~~~l~~~~~L~~L~l~~~~l~~~~~~~l~~~l~~~~~L~~L~ls~n~i~~~~~  347 (484)
                      ..+..+++|++|++++|.+++.++..++..+..+++|++|++++|.+++.+...+...+..+++|++|++++|.+++.++
T Consensus       159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~  238 (319)
T cd00116         159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA  238 (319)
T ss_pred             HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence            56666666777777776666666666665565566677777777766666666666666666667777776666666555


Q ss_pred             HHHHHHHHh-CCCcCEEeccCCCCChhHHHHHHHHHHcCCCccEEEeccCCCCchhHHHHHHHHHhcCccccEEEcCCCC
Q 011480          348 KALSEVLKF-HGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNE  426 (484)
Q Consensus       348 ~~l~~~~~~-~~~L~~L~l~~~~i~~~~~~~l~~~l~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~~L~~L~l~~n~  426 (484)
                      ..+...+.. .+.|++|++++|.+++.+...+...+..+++|+.+++++|.+++++...++..+...-+.|+++++.+|.
T Consensus       239 ~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence            555544322 3566666666666665555555555555566666666666666666665555554322456666665553

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG3735 consensus Tropomodulin and leiomodulin [Cytoskeleton] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG3735 consensus Tropomodulin and leiomodulin [Cytoskeleton] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification] Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

Original result of BLAST against Protein Data Bank

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query484
2bnh_A457 Porcine Ribonuclease Inhibitor Length = 457 2e-26
2bnh_A457 Porcine Ribonuclease Inhibitor Length = 457 2e-24
3tsr_E457 X-Ray Structure Of Mouse Ribonuclease Inhibitor Com 8e-26
1a4y_A460 Ribonuclease Inhibitor-Angiogenin Complex Length = 1e-22
1z7x_W461 X-Ray Structure Of Human Ribonuclease Inhibitor Com 2e-22
3un9_A372 Crystal Structure Of An Immune Receptor Length = 37 1e-05
1k5d_C386 Crystal Structure Of Ran-Gppnhp-Ranbp1-Rangap Compl 2e-05
1yrg_A385 The Crystal Structure Of Rna1p: A New Fold For A Gt 2e-05
3goz_A362 Crystal Structure Of The Leucine-Rich Repeat-Contai 5e-04
>pdb|2BNH|A Chain A, Porcine Ribonuclease Inhibitor Length = 457 Back     alignment and structure 
Iteration: 1

 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 97/374 (25%), Positives = 173/374 (46%), Gaps = 8/374 (2%)
Query: 37  SKQTLNEFAKELRA---FSSVDMSGRNFGDEGLFFLAESLGYNQTA-EEVSFAANGITAA 92
           +++   +    LRA    + + +     GD G+  + + L       +++S     +T A
Sbjct: 37  TEEHCKDIGSALRANPSLTELCLRTNELGDAGVHLVLQGLQSPTCKIQKLSLQNCSLTEA 96
Query: 93  GIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDILVD-NAGVERLQLSSVDLRDEGAK 151
           G       L+S   L+ L+LS NP+GD G++ LC+ L+D    +E+LQL    L     +
Sbjct: 97  GCGVLPSTLRSLPTLRELHLSDNPLGDAGLRLLCEGLLDPQCHLEKLQLEYCRLTAASCE 156
Query: 152 AIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLENST-IRSLHXXXXXXXXXXXXXXX 210
            +A +L+    L+ L ++NN I  +G   L + L +++  + +L                
Sbjct: 157 PLASVLRATRALKELTVSNNDIGEAGARVLGQGLADSACQLETLRLENCGLTPANCKDLC 216
Query: 211 XXXXXXKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYI 270
                  SLREL L  N +GD GI  L  GL S   +L  L +    I+A G   +   +
Sbjct: 217 GIVASQASLRELDLGSNGLGDAGIAELCPGLLSPASRLKTLWLWECDITASGCRDLCRVL 276
Query: 271 KNCKSLLWINLYMNDIGDEGAEKIADALKQNRT-ITTIDLGGNNIHSKGASAIARVLKDN 329
           +  ++L  ++L  N +GDEGA  + ++L Q    + ++ +   ++ +     ++ +L  N
Sbjct: 277 QAKETLKELSLAGNKLGDEGARLLCESLLQPGCQLESLWVKSCSLTAACCQHVSLMLTQN 336
Query: 330 SVITSLDLAYNPIGADGAKALSEVLKFHG-NINTLKLGWCQIGASGAEFVADMLRYNNTI 388
             +  L L+ N +G  G + L + L   G  +  L LG C++  SG   +A +L  N ++
Sbjct: 337 KHLLELQLSSNKLGDSGIQELCQALSQPGTTLRVLCLGDCEVTNSGCSSLASLLLANRSL 396
Query: 389 SILDLRANGLRDEG 402
             LDL  N + D G
Sbjct: 397 RELDLSNNCVGDPG 410
>pdb|2BNH|A Chain A, Porcine Ribonuclease Inhibitor Length = 457 Back     alignment and structure
>pdb|3TSR|E Chain E, X-Ray Structure Of Mouse Ribonuclease Inhibitor Complexed With Mouse Ribonuclease 1 Length = 457 Back     alignment and structure
>pdb|1A4Y|A Chain A, Ribonuclease Inhibitor-Angiogenin Complex Length = 460 Back     alignment and structure
>pdb|1Z7X|W Chain W, X-Ray Structure Of Human Ribonuclease Inhibitor Complexed With Ribonuclease I Length = 461 Back     alignment and structure
>pdb|3UN9|A Chain A, Crystal Structure Of An Immune Receptor Length = 372 Back     alignment and structure
>pdb|1K5D|C Chain C, Crystal Structure Of Ran-Gppnhp-Ranbp1-Rangap Complex Length = 386 Back     alignment and structure
>pdb|1YRG|A Chain A, The Crystal Structure Of Rna1p: A New Fold For A Gtpase- Activating Protein Length = 385 Back     alignment and structure
>pdb|3GOZ|A Chain A, Crystal Structure Of The Leucine-Rich Repeat-Containing Protein Legl7 From Legionella Pneumophila. Northeast Structural Genomics Consortium Target Lgr148 Length = 362 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

Original result of RPS-BLAST against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query484
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-122
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-104
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 1e-93
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 4e-89
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 4e-48
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 5e-91
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 3e-72
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 1e-68
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 4e-38
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 2e-30
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 2e-81
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 6e-75
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 9e-74
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 5e-68
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 6e-48
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 1e-30
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 4e-72
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 1e-65
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 2e-57
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 5e-32
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 9e-38
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 6e-36
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 8e-36
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 4e-33
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 3e-31
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 7e-29
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 1e-27
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 3e-29
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 3e-28
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 2e-25
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 7e-25
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 2e-22
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 3e-21
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 5e-21
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 1e-12
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 3e-11
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 8e-26
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 2e-20
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 7e-15
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 8e-14
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 4e-22
2p1m_B 594 Transport inhibitor response 1 protein; F-BOX, leu 3e-20
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 3e-17
2p1m_B 594 Transport inhibitor response 1 protein; F-BOX, leu 8e-15
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 3e-14
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 5e-21
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 2e-17
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 3e-15
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 5e-12
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 7e-12
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 1e-11
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 2e-09
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 5e-08
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 2e-20
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 7e-19
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 1e-17
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 7e-11
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 1e-06
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-18
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 3e-15
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 7e-15
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-14
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-14
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-09
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-09
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-04
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-18
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-13
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-10
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-10
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-17
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-17
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 1e-16
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 3e-15
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-13
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-10
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 4e-07
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 3e-05
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 8e-05
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 3e-17
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 2e-13
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 8e-13
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 3e-11
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 6e-10
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 1e-16
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 5e-12
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-11
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 5e-11
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 2e-15
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 7e-15
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 2e-06
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 7e-05
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 6e-15
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 6e-13
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 2e-09
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 6e-15
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-14
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 9e-13
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 4e-10
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 1e-09
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-09
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-05
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 6e-15
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 1e-14
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 1e-08
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 7e-04
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 7e-13
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 1e-12
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 5e-12
3o6n_A 390 APL1; leucine-rich repeat, protein binding; HET: N 9e-13
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 1e-12
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 4e-12
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 9e-12
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 2e-10
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-12
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 2e-09
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 8e-07
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 5e-05
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 2e-12
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 3e-08
4fmz_A347 Internalin; leucine rich repeat, structural genomi 8e-12
4fmz_A347 Internalin; leucine rich repeat, structural genomi 4e-10
4fmz_A347 Internalin; leucine rich repeat, structural genomi 1e-05
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 3e-11
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 2e-09
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 9e-09
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 3e-11
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 5e-10
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 6e-08
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 3e-06
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 3e-11
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 5e-10
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 2e-08
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 8e-07
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 1e-10
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 9e-09
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 5e-10
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 5e-10
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 8e-06
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 7e-10
4ezg_A197 Putative uncharacterized protein; internalin-A, le 9e-10
4ezg_A197 Putative uncharacterized protein; internalin-A, le 9e-07
4ezg_A197 Putative uncharacterized protein; internalin-A, le 9e-06
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 1e-09
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 4e-06
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 4e-04
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-09
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-09
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 2e-07
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 2e-09
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 4e-09
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 1e-07
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 2e-07
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-09
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 7e-08
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 1e-04
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 3e-09
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 5e-05
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 8e-05
1o6v_A466 Internalin A; bacterial infection, extracellular r 3e-09
1o6v_A 466 Internalin A; bacterial infection, extracellular r 1e-07
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 2e-08
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 8e-08
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 3e-06
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 5e-05
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 4e-08
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 2e-05
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 4e-08
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-06
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 8e-05
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 2e-04
4eco_A 636 Uncharacterized protein; leucine-rich repeats, pro 3e-04
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 4e-08
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 2e-07
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 2e-07
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 3e-07
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 6e-07
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 3e-07
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 4e-05
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 4e-07
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 2e-05
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 8e-07
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 2e-05
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 1e-06
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 2e-06
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 2e-06
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 1e-05
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 2e-05
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 4e-05
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 4e-05
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 8e-05
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 2e-04
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 3e-04
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 3e-04
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 7e-04
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
 Score =  365 bits (939), Expect = e-122
 Identities = 109/420 (25%), Positives = 180/420 (42%), Gaps = 9/420 (2%)

Query: 53  SVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNL 112
           S+D+      D      AE L   Q  + V     G+T A  K     L+ N AL  LNL
Sbjct: 7   SLDIQCEELSDARW---AELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 113 SGNPIGDEGVKCLCDIL-VDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNN 171
             N +GD GV C+   L   +  +++L L +  L   G   ++  L+    L+ L L++N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 172 MIDYSGFTSLAEALLE-NSTIRSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIG 230
           ++  +G   L E LL+    +  L L      A     LA  L      +EL +  N I 
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 231 DEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEG 290
           + G+R L  GL     +L  L + +  +++     +   + +  SL  + L  N +GD G
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243

Query: 291 AEKIADALKQ-NRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKA 349
             ++   L   +  + T+ +    I +KG   + RVL+    +  L LA N +G +GA+ 
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303

Query: 350 LSEVLKF-HGNINTLKLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQ 408
           L E L      + +L +  C   A+     + +L  N  +  L +  N L D G + L Q
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363

Query: 409 SFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDA 468
                   L  + LA  ++ D    ++A  L AN   ++  L+L+NN L   G   L ++
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH--SLRELDLSNNCLGDAGILQLVES 421
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure

Structure Templates Detected by HHsearch ?

Original result of HHsearch against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query484
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 100.0
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 100.0
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 100.0
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 100.0
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.97
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.97
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.97
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.97
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.97
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.96
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.94
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.94
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.93
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 99.93
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.93
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.93
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 99.92
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 99.92
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.92
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.92
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.92
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.92
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.91
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.91
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.91
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.91
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.91
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.9
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.9
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.9
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.9
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 99.9
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.89
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.89
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.89
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.89
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 99.88
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.88
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.88
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.87
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.87
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 99.87
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.87
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.87
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.87
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.87
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.87
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.85
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.85
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.85
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.81
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.81
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.8
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.8
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 99.79
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.79
4g8a_A 635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.78
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.77
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.76
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.76
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.75
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.75
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.74
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.74
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.74
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.73
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.73
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.72
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 99.71
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.71
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 99.71
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.7
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.69
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.69
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.69
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.68
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.67
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.67
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.67
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.66
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.66
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.66
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.65
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.65
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.65
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.65
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.64
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.63
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.58
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.57
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.51
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.51
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.51
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.5
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.5
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.49
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.49
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.48
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.46
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.44
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.43
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.43
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.41
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.4
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.39
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.37
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 99.37
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.34
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.29
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.28
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.28
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.27
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.2
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.2
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.19
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.18
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.15
2xot_A 361 Amphoterin-induced protein 1; cell adhesion, neuro 99.14
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.14
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.14
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.13
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.11
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.11
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.1
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.08
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.06
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.04
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 99.03
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.02
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.02
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.02
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.01
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.99
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.98
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 98.97
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 98.96
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.78
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.76
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.76
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.75
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.67
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.66
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.63
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.63
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 98.61
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 98.52
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.4
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.39
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.35
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.22
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.74
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 97.73
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.72
2ifg_A 347 High affinity nerve growth factor receptor; TRK, T 97.71
4fdw_A401 Leucine rich hypothetical protein; putative cell s 97.58
4fdw_A401 Leucine rich hypothetical protein; putative cell s 97.04
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 96.82
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 96.42
4gt6_A394 Cell surface protein; leucine rich repeats, putati 95.92
4gt6_A394 Cell surface protein; leucine rich repeats, putati 87.34
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
Probab=100.00  E-value=6.9e-45  Score=361.78  Aligned_cols=414  Identities=26%  Similarity=0.376  Sum_probs=235.9

Q ss_pred             ccceEEeCCCCCCChhHHHHHHHHhccCCCcceEecccCCCCHHHHHHHHHHhhcCCCCCEEecCCCCCChhHHHHHHHH
Q 011480           49 RAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNLSGNPIGDEGVKCLCDI  128 (484)
Q Consensus        49 ~~l~~L~ls~~~~~~~~~~~l~~~l~~~~~L~~L~l~~~~l~~~~~~~l~~~l~~~~~L~~L~L~~~~i~~~~~~~l~~~  128 (484)
                      +++++|+++++.+++..+..+   +..+++|++|++++|++++.++..++..+..+++|++|++++|.+++.++..+...
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~---~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~   79 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAEL---LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG   79 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHH---HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT
T ss_pred             ccceehhhhhcccCchhHHHH---HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHH
Confidence            345566666666555543322   22335566666666666655555555555555666666666666555554444443


Q ss_pred             HHhCC-CcCEEEeeccCCChHHHHHHHHHHhcCCCccEEEccCCCCCchHHHHHHHHHhc-CCCccEEEcCCCCCChHHH
Q 011480          129 LVDNA-GVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNNMIDYSGFTSLAEALLE-NSTIRSLHLNGNYGGALGA  206 (484)
Q Consensus       129 l~~~~-~L~~L~l~~~~~~~~~~~~l~~~l~~~~~L~~L~l~~~~l~~~~~~~l~~~l~~-~~~L~~L~l~~~~~~~~~~  206 (484)
                      +.... +|++|++++|.+++.++..++..+..+++|++|++++|.+++.+...++..+.. .++|++|++++|.++....
T Consensus        80 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~  159 (461)
T 1z7x_W           80 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC  159 (461)
T ss_dssp             TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred             HhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHH
Confidence            32211 466666666666655555555555555666666666666655555555544332 3456666666666655555


Q ss_pred             HHHHHHhhcCCCcCEEEccCCCCChhHHHHHHHhhccCCCcceEEEccCCCCChhhHHHHHHHHhcCCCCcEEEcCCCCC
Q 011480          207 NALAKGLEGNKSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDI  286 (484)
Q Consensus       207 ~~l~~~l~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~~~~~L~~L~l~~~~i~~~~~~~l~~~l~~~~~L~~L~l~~~~l  286 (484)
                      ..++..+..+++|++|++++|.+++.++..+...+....++|++|++++|.+++.+...++..+..+++|++|++++|.+
T Consensus       160 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l  239 (461)
T 1z7x_W          160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL  239 (461)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred             HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcC
Confidence            55555555566666666666665555555555544433345666666666666555555555555666666666666666


Q ss_pred             CcHHHHHHHHHHH-hCCCccEEEccCCCCChhHHHHHHHHhhcCCCcCEEECCCCCCChhHHHHHHHHHHhC-CCcCEEe
Q 011480          287 GDEGAEKIADALK-QNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKALSEVLKFH-GNINTLK  364 (484)
Q Consensus       287 ~~~~~~~l~~~l~-~~~~L~~L~l~~~~l~~~~~~~l~~~l~~~~~L~~L~ls~n~i~~~~~~~l~~~~~~~-~~L~~L~  364 (484)
                      ++.++..++..+. .+++|++|++++|.+++.++..++..+..+++|++|++++|.+++.+...+...+... ++|++|+
T Consensus       240 ~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~  319 (461)
T 1z7x_W          240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW  319 (461)
T ss_dssp             HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred             ChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeE
Confidence            5555555544443 2456666666666666665555555555566666666666666555555555544432 3666666


Q ss_pred             ccCCCCChhHHHHHHHHHHcCCCccEEEeccCCCCchhHHHHHHHHHhcCccccEEEcCCCCCChhHHHHHHHHHHhCCc
Q 011480          365 LGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANED  444 (484)
Q Consensus       365 l~~~~i~~~~~~~l~~~l~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~l~~~~~  444 (484)
                      +++|.+++.+...+...+..+++|+.|++++|.+++.++..+...+...+++|++|++++|++++.++..+...+..+++
T Consensus       320 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~  399 (461)
T 1z7x_W          320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS  399 (461)
T ss_dssp             CTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC
T ss_pred             cCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCC
Confidence            66666665555555555556666666666666666665555555544333456666666666666666666665555554


Q ss_pred             cceeEeeccCCcCchhhhhhhhh
Q 011480          445 VAVTSLNLANNFLTKFGQSALTD  467 (484)
Q Consensus       445 ~~L~~l~l~~n~i~~~~~~~l~~  467 (484)
                        |++|++++|++++.++..+.+
T Consensus       400 --L~~L~l~~N~i~~~~~~~l~~  420 (461)
T 1z7x_W          400 --LRELDLSNNCLGDAGILQLVE  420 (461)
T ss_dssp             --CCEEECCSSSCCHHHHHHHHH
T ss_pred             --ccEEECCCCCCCHHHHHHHHH
Confidence              666666666666666555554
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 484
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 7e-23
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 5e-20
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 4e-18
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 4e-18
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-17
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 6e-17
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-16
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-16
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 3e-16
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 4e-16
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-15
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-15
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 6e-15
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 9e-15
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-14
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 2e-12
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 9e-12
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 1e-10
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 6e-04
d1z7xw1 460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.003
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 3e-19
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 1e-18
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 4e-18
d2ca6a1344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 9e-18
d2ca6a1 344 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom 3e-09
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 3e-13
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 9e-13
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 1e-12
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 2e-11
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 8e-09
d1pgva_167 c.10.1.1 (A:) Tropomodulin C-terminal domain {nema 2e-05
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 2e-11
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 3e-11
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 1e-08
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 5e-08
d1io0a_166 c.10.1.1 (A:) Tropomodulin C-terminal domain {Chic 1e-07
d2astb2284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 1e-05
d2astb2 284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 0.003
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 7e-05
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 0.002
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (244), Expect = 7e-23
 Identities = 108/420 (25%), Positives = 173/420 (41%), Gaps = 9/420 (2%)

Query: 53  SVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSNIALKTLNL 112
           S+D+      D     L   L   Q    V     G+T A  K     L+ N AL  LNL
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQV---VRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 113 SGNPIGDEGVKCLCDIL-VDNAGVERLQLSSVDLRDEGAKAIAELLKNNSILRVLELNNN 171
             N +GD GV C+   L   +  +++L L +  L   G   ++  L+    L+ L L++N
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 172 MIDYSGFTSLAEALLENSTI-RSLHLNGNYGGALGANALAKGLEGNKSLRELHLHGNSIG 230
           ++  +G   L E LL+       L L      A     LA  L      +EL +  N I 
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182

Query: 231 DEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVAEYIKNCKSLLWINLYMNDIGDEG 290
           + G+R L  GL     +L  L + +  +++     +   + +  SL  + L  N +GD G
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242

Query: 291 AE-KIADALKQNRTITTIDLGGNNIHSKGASAIARVLKDNSVITSLDLAYNPIGADGAKA 349
                   L  +  + T+ +    I +KG   + RVL+    +  L LA N +G +GA+ 
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302

Query: 350 LSEVLKFHGNINTL-KLGWCQIGASGAEFVADMLRYNNTISILDLRANGLRDEGAKCLAQ 408
           L E L   G       +  C   A+     + +L  N  +  L +  N L D G + L Q
Sbjct: 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362

Query: 409 SFKVVNEALTSIDLAFNEIRDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDA 468
                   L  + LA  ++ D    ++A  L AN   ++  L+L+NN L   G   L ++
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH--SLRELDLSNNCLGDAGILQLVES 420
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Length = 167 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Length = 166 Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

Original result of HHsearch against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query484
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 100.0
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 100.0
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.97
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 99.97
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.81
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.79
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.77
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.75
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 99.63
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 99.63
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 99.59
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 99.57
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.51
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.49
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.44
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.42
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.39
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.37
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.36
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.35
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.34
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.3
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.27
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.24
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.19
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.18
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.1
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.09
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.05
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.96
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.95
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.88
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.84
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 98.81
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.76
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.76
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 98.35
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 98.34
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.28
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 98.23
d2ifga3156 High affinity nerve growth factor receptor, N-term 97.9
d2ifga3156 High affinity nerve growth factor receptor, N-term 97.82
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=307.42  Aligned_cols=438  Identities=18%  Similarity=0.249  Sum_probs=337.3

Q ss_pred             chhhHHHHHHHHHHcccceEEeCCCCCCChhHHHHHHHHhccCCCcceEecccCCCCHHHHHHHHHHhhcC-CCCCEEec
Q 011480           34 FRESKQTLNEFAKELRAFSSVDMSGRNFGDEGLFFLAESLGYNQTAEEVSFAANGITAAGIKAFDGVLQSN-IALKTLNL  112 (484)
Q Consensus        34 ~~~~~~~l~~~~~~~~~l~~L~ls~~~~~~~~~~~l~~~l~~~~~L~~L~l~~~~l~~~~~~~l~~~l~~~-~~L~~L~L  112 (484)
                      ...+...+.+++..+++++.|+|++|.+++.++..++..+..+++|++|++++|++++.++..++..+... .+|++|++
T Consensus        12 ~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L   91 (460)
T d1z7xw1          12 EELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL   91 (460)
T ss_dssp             CCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEEC
T ss_pred             CcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEEC
Confidence            34445556667777778888888888888888888888888888888888888888888888777766543 36888888


Q ss_pred             CCCCCChhHHHHHHHHHHhCCCcCEEEeeccCCChHHHHHHHHHHhc-CCCccEEEccCCCCCchHHHHHHHHHhcCCCc
Q 011480          113 SGNPIGDEGVKCLCDILVDNAGVERLQLSSVDLRDEGAKAIAELLKN-NSILRVLELNNNMIDYSGFTSLAEALLENSTI  191 (484)
Q Consensus       113 ~~~~i~~~~~~~l~~~l~~~~~L~~L~l~~~~~~~~~~~~l~~~l~~-~~~L~~L~l~~~~l~~~~~~~l~~~l~~~~~L  191 (484)
                      ++|.+++.++..++..+..+++|++|++++|.+++.++..+...+.. .............+...+...+...+...+.+
T Consensus        92 ~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (460)
T d1z7xw1          92 QNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF  171 (460)
T ss_dssp             TTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTC
T ss_pred             CCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccc
Confidence            88888888877777777777888888888888887777777666543 23455666666666666677777777778888


Q ss_pred             cEEEcCCCCCChHHHHHHHHHhhcC-CCcCEEEccCCCCChhHHHHHHHhhccCCCcceEEEccCCCCChhhHHHHH-HH
Q 011480          192 RSLHLNGNYGGALGANALAKGLEGN-KSLRELHLHGNSIGDEGIRALMSGLSSRKGKLAVLDIGNNSISAKGAFHVA-EY  269 (484)
Q Consensus       192 ~~L~l~~~~~~~~~~~~l~~~l~~~-~~L~~L~l~~~~l~~~~~~~~~~~l~~~~~~L~~L~l~~~~i~~~~~~~l~-~~  269 (484)
                      +.+.++.+.........+...+... .....+++..+.+...+.......+.... .++.+++++|.+......... ..
T Consensus       172 ~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~-~~~~l~~~~n~~~~~~~~~~~~~~  250 (460)
T d1z7xw1         172 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKA-SLRELALGSNKLGDVGMAELCPGL  250 (460)
T ss_dssp             CEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCT-TCCEEECCSSBCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhcccccccccc-cccccchhhccccccccchhhccc
Confidence            8888888877666665555555443 35677888888777766666665554433 788888888887766543333 33


Q ss_pred             HhcCCCCcEEEcCCCCCCcHHHHHHHHHHHhCCCccEEEccCCCCChhHHHHHHHHhhc-CCCcCEEECCCCCCChhHHH
Q 011480          270 IKNCKSLLWINLYMNDIGDEGAEKIADALKQNRTITTIDLGGNNIHSKGASAIARVLKD-NSVITSLDLAYNPIGADGAK  348 (484)
Q Consensus       270 l~~~~~L~~L~l~~~~l~~~~~~~l~~~l~~~~~L~~L~l~~~~l~~~~~~~l~~~l~~-~~~L~~L~ls~n~i~~~~~~  348 (484)
                      ......++.+++++|.+.......+...+..++.++.+++++|.++++++..++..+.. ...|+.++++++.+++.++.
T Consensus       251 ~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~  330 (460)
T d1z7xw1         251 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS  330 (460)
T ss_dssp             TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhh
Confidence            34467789999999988888877787778888889999999999998888888777654 46899999999999888888


Q ss_pred             HHHHHHHhCCCcCEEeccCCCCChhHHHHHHHHHH-cCCCccEEEeccCCCCchhHHHHHHHHHhcCccccEEEcCCCCC
Q 011480          349 ALSEVLKFHGNINTLKLGWCQIGASGAEFVADMLR-YNNTISILDLRANGLRDEGAKCLAQSFKVVNEALTSIDLAFNEI  427 (484)
Q Consensus       349 ~l~~~~~~~~~L~~L~l~~~~i~~~~~~~l~~~l~-~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~~L~~L~l~~n~i  427 (484)
                      .+...+..+++|++|++++|.+++.+...+.+.+. .++.|++|++++|.|++.++..++..+.. +++|++|+|++|+|
T Consensus       331 ~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~-~~~L~~L~Ls~N~i  409 (460)
T d1z7xw1         331 HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA-NHSLRELDLSNNCL  409 (460)
T ss_dssp             HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH-CCCCCEEECCSSSC
T ss_pred             hcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhc-CCCCCEEECCCCcC
Confidence            88888888889999999999998888888887775 46779999999999999988888887764 47899999999999


Q ss_pred             ChhHHHHHHHHHHhCCccceeEeeccCCcCchhhhhhhhhhhhhhhh
Q 011480          428 RDDGAFAIAQALKANEDVAVTSLNLANNFLTKFGQSALTDAKDLVYE  474 (484)
Q Consensus       428 ~~~~~~~l~~~l~~~~~~~L~~l~l~~n~i~~~~~~~l~~~~~~~~~  474 (484)
                      ++.++..+++.++.+.. .|+.|++.+|.+.+...+.++++......
T Consensus       410 ~~~g~~~l~~~l~~~~~-~L~~l~l~~~~~~~~~~~~l~~l~~~~~~  455 (460)
T d1z7xw1         410 GDAGILQLVESVRQPGC-LLEQLVLYDIYWSEEMEDRLQALEKDKPS  455 (460)
T ss_dssp             CHHHHHHHHHHHTSTTC-CCCEEECTTCCCCHHHHHHHHHHHHHCTT
T ss_pred             CHHHHHHHHHHHHhCCC-ccCEEECCCCCCCHHHHHHHHHHHHhCCC
Confidence            99999999888876663 68899999999988888888776655443
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure